Search for: "Paddock Laboratories Inc" Results 21 - 35 of 35
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
24 Jun 2013, 10:08 am by Sheppard Mullin
Subsequently, Actavis, Inc. and Paddock Laboratories filed separate Abbreviated New Drug Applications pursuant to the Hatch-Waxman Act (21 U.S.C. [read post]
24 Jun 2013, 6:08 am by Bradley Graveline
Subsequently, Actavis, Inc. and Paddock Laboratories filed separate Abbreviated New Drug Applications pursuant to the Hatch-Waxman Act (21 U.S.C. [read post]
28 Sep 2010, 3:14 pm by Kelly
Par Pharmaceutical, Inc; Schering-Plough Healthcare Products, Inc. et al. v. [read post]
8 Dec 2010, 2:20 am by Marie Louise
: Daiichi Sankyo Co Ltd v Comptroller General of Patents (The SPC Blog) Coversyl (Perindopril) – Australia: FCAFC: Servier denied patent amendment on appeal: Les Laboratoires Servier v Apotex (Patentology) Prandin (Repaglinide) – US: Paddock fails to dismiss Novo’s Prandin patent suit (Patent Docs) Spiriva (Tiotropium bromide monohydrate) – Israel: Patent status in question, in need of legislative fix (America-Israel Patent Law) Temodar (Temozolomide) – US:… [read post]
3 Aug 2011, 3:31 am by Marie Louise
Paddock (Orange Book Blog) (Holman’s Biotech IP Blog) Cetrorelix – UK: Non-payment of Cetrorelix fee on time fatal for SPC: Case BLO/252/11 The Administrators of the Tulane Education Fund (The SPC Blog) Detrol (Tolterodine tartrate) – US: Pfizer files patent infringement complaint against Torrent Pharma in response to Para IV certification filing (Patent Docs) Galantamine – EU: CJEU ruling in Case C-427/09 Generics (UK) Ltd v Synaptech (The SPC Blog) (EPLAW)… [read post]
1 Aug 2011, 6:03 am by Stephen Albainy-Jenei
Paddock Laboratories, Inc., followed a trend started in Festo X and applied in several other doctrine of equivalents decisions by the Federal Circuit in the nine years since the Supreme Court established foreseeability as a basis for rebutting the presumption of prosecution history estoppel. [read post]